Considering colorectal cancer (CRC) cells are more responsive to pro-necroptosis stimuli compared with other cancer types, it would be interesting to explore if ABIN-1 deficiency improves the necroptosis-based cancer therapy in the CRC xenograft model. This evidence concerns the gene TNIP1 and colorectal carcinoma.